INVO Fertility Financials - Benzinga

INVO Fertility Inc

IVFNASDAQ

Trade with Public

Trade with Public

$0.9691

0.00510.53%

At close: Sep 11, 5:00 PM EST

$0.9656

-0.0035-0.36%

After Hours: Sep 11, 7:23 PM EST

Overview News Earnings Forecast EventsFinancialsSentiment Ownership Compare Stock Report

INVO Fertility Financials

INVO Fertility (IVF) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Dow Tumbles Over 250 Points Amid Rising Iran Concerns: Investor Sentiment Weakens, But Fear Index Remains In ‘Greed’ Zone

The CNN Fear & Greed Index tracks market sentiment using 7 indicators, currently showing a decline but remaining in the Greed zone at 59.9.

Avi Kapoor

PRO
INVO Fertility Q2 EPS $0.35 Beats $(0.65) Estimate, Sales $2.175M Miss $2.709M Estimate

INVO Fertility (NASDAQ:IVF) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $(0.65) by 153.85 percent. This is a 100.11 percent increase over losses of $(318.00) per share

Benzinga Newsdesk

PRO
INVO Fertility Q1 EPS $(3.38) Misses $(1.25) Estimate, Sales $2.015M Beat $1.980M Estimate

INVO Fertility (NASDAQ:IVF) reported quarterly losses of $(3.38) per share which missed the analyst consensus estimate of $(1.25) by 170.4 percent. This is a 99.78 percent increase over losses of $(1.50 thousand) per

Benzinga Newsdesk

PRO
INVO Fertility Q4 EPS $(40.40) Misses $(2.75) Estimate, Sales $1.583M Miss $1.927M Estimate

INVO Fertility (NASDAQ:IVF) reported quarterly losses of $(40.40) per share which missed the analyst consensus estimate of $(2.75) by 1369.09 percent. This is a 96.28 percent increase over losses of $(1.08 thousand) per

Benzinga Newsdesk

PRO
INVO Fertility Announced Restatement Of Unaudited Q1, Q2 And Q3 2025 Financials; Audit Committee Says Financial Statements Should Not Be Relied Upon; Errors Do Not Impact Revenue Or Loss From Operations

Benzinga Newsdesk

Dow Falls Over 300 Points; General Motors Posts Upbeat Earnings

Avi Kapoor